Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAS: Montelukast Add-on in Uncontrolled Asthma
NCT00755794Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of montelukast in asthma, sponsored by Organon & Co. Primary endpoint: Percentage of patients with asthma who will be controlled at 8 weeks. Started Jun 2006; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00755794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755794.